Back to search

Cell proliferation and apoptosis during prostatic tumor xenograft involution and regrowth after castration

Data up to Jan 2025

Published1996
Citations62
References27

Total Citations Per Year

Abstract

References (27)

Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer.

1992 • 1,063 citations

Important Advances in Oncology

1991 • 768 citations

Activation of Programmed Cell Death in the Rat Ventral Prostate after Castration*

1988 • 730 citations

Apoptosis and the regulation of cell numbers in normal and neoplastic tissues: an overview

1992 • 600 citations

Detection of the apoptosis-suppressing oncoprotein bc1-2 in hormone-refractory human prostate cancers.

1993 • 597 citations

Programmed cell death during regression of PC-82 human prostate cancer following androgen ablation.

1990 • 485 citations

Internucleosomal DNA Cleavage Should not be the Sole Criterion for Identifying Apoptosis

1992 • 462 citations

Adaptation versus selection as the mechanism responsible for the relapse of prostatic cancer to androgen ablation therapy as studied in the Dunning R-3327-H adenocarcinoma.

1981 • 382 citations

Important advances in oncology 1994

1994 • 282 citations

Relationship between DNA fragmentation and apoptosis in the programmed cell death in the rat prostate following castration

1989 • 266 citations

Hormone-regulated apoptosis results from reentry of differentiated prostate cells onto a defective cell cycle.

1992 • 245 citations

Apoptosis and Its Role in Human Disease

1994 • 232 citations

Serum prostate specific antigen levels in mice bearing human prostate LNCaP tumors are determined by tumor volume and endocrine and growth factors.

1992 • 228 citations

The effect of estrone-progesterone treatment on cell proliferation kinetics of hormone-dependent GR mouse mammary tumors.

1975 • 218 citations

Cell death via apoptosis and its relationship to growth, development and differentiation of both tumour and normal cells.

1990 • 216 citations

Cell proliferation, DNA repair, and p53 function are not required for programmed death of prostatic glandular cells induced by androgen ablation.

1993 • 201 citations

Activation of a Ca2+−Mg2+‐dependent endonuclease as an early event in castration‐induced prostatic cell death

1988 • 176 citations

Pathologic changes associated with androgen deprivation therapy for prostate cancer

1991 • 161 citations

Regulation of prostate growth

1991 • 159 citations

Castration therapy rapidly induces apoptosis in a minority and decreases cell proliferation in a majority of human prostatic tumors.

1995 • 158 citations

Prostate Specific Antigen in Hormonally Treated Stage D2 Prostate Cancer: Is it always an Accurate Indicator of Disease Status?

1991 • 124 citations

Growth factors and their receptors as determinants in the proliferation and metastasis of human prostate cancer

1993 • 123 citations

Prostatic cell lineage markers: Emergence of BCL2+ cells of human prostate cancer xenograft LuCaP 23 following castration

1996 • 81 citations

Castration induces apoptosis in the ventral prostate but not in an androgen-sensitive prostatic adenocarcinoma in the rat.

1994 • 54 citations

Prostatic tumor regrowth after initially successful castration therapy may be related to a decreased apoptotic cell death rate.

1994 • 44 citations

Castration rapidly results in a major reduction in epithelial cell numbers in the rat prostate, but not in the highly differentiated dunning R3327 prostatic adenocarcinoma

1993 • 41 citations

Advances and controversies in the study of programmed cell death/apoptosis in the development of and therapy for cancer

1994 • 40 citations

Cited By (0)

No citing papers found in database

Cell proliferation and apoptosis during prostatic tumor xenograft involution and regrowth… (1996) – International Journal of Cancer | Metascience Observatory Explorer